Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. (Q46748115)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. |
scientific article |
Statements
1 reference
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. (English)
1 reference
Everett E Vokes
1 reference
Martin J Edelman
1 reference
Dee Watson
1 reference
Xiaofei Wang
1 reference
Carl Morrison
1 reference
Robert A Kratzke
1 reference
Scott Jewell
1 reference
Lydia Hodgson
1 reference
Ann M Mauer
1 reference
Ajeet Gajra
1 reference
Gregory A Masters
1 reference
Michelle Bedor
1 reference
Mark J Green
1 reference
1 February 2008
1 reference
1 reference
26
1 reference
6
1 reference
848-855
1 reference
Identifiers
1 reference
1 reference